Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices | News
Search Refinements

Drug Delivery Devices News

View news from other Medical Devices sectors:
1-15 of 569 results
Medtronic starts US study of DES to treat bifurcation lesions in patients with CAD
By MDBR Staff Writer
Medtronic has started the US clinical study for the evaluation of safety and efficacy of drug-eluting stents (DES) to treat bifurcation lesions in patients with coronary artery disease (CAD).
Specialty Devices > Drug Delivery Devices > News
United Therapeutics to buy SteadyMed in $216m deal
By MDBR Staff Writer
United Therapeutics has signed an agreement to acquire specialty pharmaceutical firm SteadyMed in a deal worth $216m.
Specialty Devices > Drug Delivery Devices > News
Precision Therapeutics signs LOI to buy remaining Helomics shares
US-based Precision Therapeutics has signed a Letter of Intent (LOI) to acquire the remainder of the equity in Helomics.
Specialty Devices > Drug Delivery Devices > News
FDA approves Medtronic's drug-coated balloon to treat long SFA lesions
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has approved Medtronic‘s In.Pact Admiral drug-coated balloon for the treatment of long superficial femoral artery lesions up to 360mm in patients with peripheral artery disease.
Specialty Devices > Drug Delivery Devices > News
Medtronic launches OptiSphere embolization spheres in US
By MDBR Staff Writer
Irish medical technology firm Medtronic has introduced OptiSphere resorbable embolic platform for embolization of hypervascular tumors in the US.
Specialty Devices > Drug Delivery Devices > News
Surmodics to license SurVeil drug-coated balloon device to Abbott
By MDBR Staff Writer
Surmodics, a provider of surface modification, drug delivery, and in vitro diagnostic technologies to the healthcare industry, has agreed to exclusively license its SurVeil drug-coated balloon device to Abbott.
Specialty Devices > Drug Delivery Devices > News
FDA approves Photocure's new drug and device combination to detect bladder cancer
By MDBR Staff Writer
Norway-based Photocure has secured approval from the US Food and Drug Administration (FDA) for new drug and device combination to detect bladder cancer.
Specialty Devices > Drug Delivery Devices > News
PharmaJet’s needle-free injector succeeds in poliovirus vaccine administration study
By MDBR Staff Writer
A study has found that PharmaJet’s needle-free injection was superior to needle and syringe for fractional dose poliovirus vaccine campaigns.
Specialty Devices > Drug Delivery Devices > News
Bayer’s Amikacin Inhale fails to meet primary end point in phase III clinical study
By MDBR Staff Writer
Bayer’s Amikacin Inhale has failed to meet the primary end point in a global phase III clinical study program.
Specialty Devices > Drug Delivery Devices > News
Amgen introduces Enbrel Mini single-dose cartridges with reusable auto-injector
By MDBR Staff Writer
Amgen has announced the US launch of Enbrel Mini single-dose prefilled cartridge with AutoTouch reusable autoinjector tp provide additional administration option for Enbrel (Etanercept) users.
Specialty Devices > Drug Delivery Devices > News
Takeda, Portal Instruments partner to develop needle-free drug delivery device
By MDBR Staff Writer
Japan drugmaker Takeda has collaborated with medical device firm Portal Instruments to develop and commercialize needle-free drug delivery device.
Specialty Devices > Drug Delivery Devices > News
Valeritas’ study shows V-Go device reduced A1C and insulin requirements in type 2 diabetes patients
By MDBR Staff Writer
Medical technology firm Valeritas’ proof-of-concept study has showed that V-Go wearable insulin delivery device along with simplified insulin titration algorithm significantly reduced A1C and insulin requirements in patients with type 2 diabetes.
Specialty Devices > Drug Delivery Devices > News
Medinol gets CE mark for EluNIR drug eluting stent
By MDBR Staff Writer
Israel-based Medinol has secured CE mark approval for its EluNIR ridaforolimus-eluting coronary stent system.
Specialty Devices > Drug Delivery Devices > News
LEO Science & Tech Hub, Elektrofi to advance formulation technology for dermatological drug delivery
LEO Science & Tech Hub, an R&D unit of LEO Pharma, has signed a collaboration agreement with Cambridge-based biotechnology company Elektrofi to explore advanced formulation technology for dermatological drug delivery.
Specialty Devices > Drug Delivery Devices > News
Medtronic gets Japanese regulatory approval for IN.PACT admiral drug-coated balloon
Medtronic announced that the IN.PACT admiral drug-coated balloon (DCB) received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of peripheral artery disease (PAD) in the upper leg - specifically, in the thigh (superficial femoral arteries (SFA)) and behind the knee (popliteal arteries).
Specialty Devices > Drug Delivery Devices > News
1-15 of 569 results